EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies

Yuxi Ma, Xiaohui Zhang iD, Cuiwei Liu, Yanxia Zhao

MedComm · 2024-12 · 5 (12)

DOI: 10.1002/mco2.70009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 28.11.2024. Verfasst von Yuxi Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 486 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Hengrui Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) composed of various biologically active constituents, such as proteins, nucleic acids, lipids, and metabolites, have emerged as a noteworthy mode of intercellular communication. There are several categories of EVs, including exosomes, microvesicles, and apoptotic bodies, which largely differ in their mechanisms of formation and secretion. The amount of evidence indicated that changes in the EV quantity and composition play a role in multiple aspects of cancer development, such as the transfer of oncogenic signals, angiogenesis, metabolism remodeling, and immunosuppressive effects. As EV isolation technology and characteristics recognition improve, EVs are becoming more commonly used in the early diagnosis and evaluation of treatment effectiveness for cancers. Actually, EVs have sparked clinical interest in their potential use as delivery vehicles or vaccines for innovative antitumor techniques. This review will focus on the function of biological molecules contained in EVs linked to cancer progression and their participation in the intricate interrelationship within the tumor microenvironment. Furthermore, the potential efficacy of an EV‐based liquid biopsy and delivery cargo for treatment will be explored. Finally, we explicitly delineate the limitations of EV‐based anticancer therapies and provide an overview of the clinical trials aimed at improving EV development.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscancercargochallengesdelivery vehiclesexosomesextracellular vesiclestherapy resistancetumor microenvironment

Autor:innen und Institutionen

  • Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
  • Hubei Key Laboratory of Precision Radiation Oncology Wuhan China.
  • Cancer Center Institute of Radiation Oncology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
  • Cancer Center Hubei Key Laboratory of Cell Homeostasis College of Life Sciences TaiKang Center for Life and Medical Sciences Wuhan University Wuhan China.

ORCID-Profile: Xiaohui Zhang

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Hengrui Medicine

Zitieren

APA

Ma, Y., Zhang, X., Liu, C., & Zhao, Y. (2024). Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies. MedComm, 5(12). https://doi.org/10.1002/mco2.70009

Vancouver

Ma Y, Zhang X, Liu C, Zhao Y. Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies. MedComm. 2024;5(12). doi:10.1002/mco2.70009

BibTeX
@article{Ma2024,
  author = {Ma, Yuxi and Zhang, Xiaohui and Liu, Cuiwei and Zhao, Yanxia},
  title = {Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {12},
  doi = {10.1002/mco2.70009}
}
Kostenlos starten →